Research programme: kinase inhibitors - OncoTherapy Science/Carna Biosciences/CrystalGenomics
Latest Information Update: 28 Oct 2010
At a glance
- Originator Carna Biosciences; CrystalGenomics; OncoTherapy Science
- Class Small molecules
- Mechanism of Action Phosphotransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Cancer